{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"A Health Podyssey","title":"Scott Howell on the Very Large Costs of Drug Utilization Management","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/8c8a808d\"></iframe>","width":"100%","height":180,"duration":1954,"description":"Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.","thumbnail_url":"https://img.transistorcdn.com/RneDq6FP97HYBXbb6ygZjKJa8RJU_wIDSHFVqnbfKe8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE0ODU4LzE2MDE0/MDI1NzEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}